Related Experiment Video
Updated: Aug 14, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
MicroRNA-32 Suppression: its Effects on Prostate Cancer Cells' Capability to Proliferate and Migrate
Farah A Al-Marzook1, Duha Maithem Hassan1, Maha Waleed Alghazal2
1College of Medical and Health Technologies, Al-Zahraa University for Women, Karbala, Iraq.
Introduction:
This paper sought to scrutinize the role of microRNA-32 (miR-32) on the growth and migration as well as on the expression of metastatic genes in PC3 cells of prostate cancer in vitro.
Methods:
Subsequent transfection of cells with miR-32 mimics, miR-32 inhibitor, negative control (NC), cell proliferation using MTT, and apoptosis by ELISA were performed. Furthermore, qRT-PCR was directed to measure the expression levels of matrix metalloproteinase 2 (MMP2) and vascular endothelial growth factors (VEGF) as metastatic and angiogenesis genes in the progression of PC3.
Results:
miR-32 was overexpressed in PC3 cells compared to normal cells (P<0.001). Down-regulation of miR-32 obstructs in vitro proliferation and migration while intensifying the apoptosis rate in PC3 cells. Also, we found that miR-32 negatively modulates the expression of VEGF and MMP2 in PC3 cells.
Conclusion:
These results indicate that the suppression of miR-32 might offer an auxiliary treatment procedure for addressing the invasion, progression, and metastasis in PCa patients by improving cell apoptosis.
Insights
microRNA-32 (miR-32) promotes prostate cancer cell growth and metastasis. Suppressing miR-32 inhibits PC3 cell proliferation and migration, offering a potential therapeutic strategy for prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prostate cancer (PCa) is a significant health concern.
- Understanding the molecular mechanisms driving PCa progression is crucial.
Purpose of the Study:
- To investigate the role of microRNA-32 (miR-32) in prostate cancer cell line PC3.
- To assess the impact of miR-32 on cell growth, migration, and metastatic gene expression in vitro.
Main Methods:
- PC3 cells were transfected with miR-32 mimics or inhibitors.
- Cell proliferation (MTT assay) and apoptosis (ELISA) were evaluated.
- Quantitative real-time PCR (qRT-PCR) measured expression of VEGF and MMP2.
Main Results:
- miR-32 was significantly overexpressed in PC3 cells.
- Down-regulating miR-32 reduced proliferation and migration while increasing apoptosis in PC3 cells.
- miR-32 negatively regulated the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinase 2 (MMP2).
Conclusions:
- miR-32 plays a critical role in promoting prostate cancer cell growth and metastasis.
- Suppression of miR-32 may serve as an adjunctive therapeutic approach for prostate cancer.
- Targeting miR-32 could potentially inhibit invasion, progression, and metastasis in PCa patients by enhancing apoptosis.
Related Concept Videos
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

